These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31161717)

  • 1. Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research.
    Hosokawa Y; Hanafusa T; Imagawa A
    J Diabetes Investig; 2019 Sep; 10(5):1158-1164. PubMed ID: 31161717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-producing cells derived from 'induced pluripotent stem cells' of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis-related genes.
    Hosokawa Y; Toyoda T; Fukui K; Baden MY; Funato M; Kondo Y; Sudo T; Iwahashi H; Kishida M; Okada C; Watanabe A; Asaka I; Osafune K; Imagawa A; Shimomura I
    J Diabetes Investig; 2017 Aug; 9(3):481-93. PubMed ID: 28796422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells.
    Zhu FF; Zhang PB; Zhang DH; Sui X; Yin M; Xiang TT; Shi Y; Ding MX; Deng H
    Diabetologia; 2011 Sep; 54(9):2325-36. PubMed ID: 21755313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges.
    Quiskamp N; Bruin JE; Kieffer TJ
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
    Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
    Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
    Bose B; Katikireddy KR; Shenoy PS
    Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Pancreatic β-cells From iPSCs and their Potential for Type 1 Diabetes Mellitus Replacement Therapy and Modelling.
    Csobonyeiova M; Polak S; Danisovic L
    Exp Clin Endocrinol Diabetes; 2020 May; 128(5):339-346. PubMed ID: 30114722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
    Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
    Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of iPSC-derived beta cells from patients with diabetes.
    Maxwell KG; Millman JR
    Cell Rep Med; 2021 Apr; 2(4):100238. PubMed ID: 33948571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
    Dadheech N; James Shapiro AM
    Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In search of a surrogate: engineering human beta cell lines for therapy.
    Newby BN; Terada N; Mathews CE
    Trends Endocrinol Metab; 2014 Aug; 25(8):378-80. PubMed ID: 24958526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols.
    Liew CG
    Rev Diabet Stud; 2010; 7(2):82-92. PubMed ID: 21060967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.
    Kudva YC; Ohmine S; Greder LV; Dutton JR; Armstrong A; De Lamo JG; Khan YK; Thatava T; Hasegawa M; Fusaki N; Slack JM; Ikeda Y
    Stem Cells Transl Med; 2012 Jun; 1(6):451-61. PubMed ID: 23197849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
    Cierpka-Kmiec K; Wronska A; Kmiec Z
    Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
    Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
    Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell-Based Therapies: A New Ray of Hope for Diabetic Patients.
    Khan J; Alexander A; Agrawal M; Ajazuddin ; Dubey SK; Siddique S; Saraf S; Saraf S
    Curr Stem Cell Res Ther; 2019; 14(2):146-151. PubMed ID: 30280677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Cell replacement as a treatment for type 1 diabetes: an overview of possible cell sources and current axes of research.
    Vieira A; Courtney M; Druelle N; Avolio F; Napolitano T; Hadzic B; Navarro-Sanz S; Ben-Othman N; Collombat P
    Diabetes Obes Metab; 2016 Sep; 18 Suppl 1():137-43. PubMed ID: 27615143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MECHANISMS IN ENDOCRINOLOGY: Towards the clinical translation of stem cell therapy for type 1 diabetes.
    Espes D; Lau J; Carlsson PO
    Eur J Endocrinol; 2017 Oct; 177(4):R159-R168. PubMed ID: 28487297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control.
    Kim MJ; Lee EY; You YH; Yang HK; Yoon KH; Kim JW
    Stem Cell Res; 2020 Oct; 48():101958. PubMed ID: 32882526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo.
    Pellegrini S; Ungaro F; Mercalli A; Melzi R; Sebastiani G; Dotta F; Broccoli V; Piemonti L; Sordi V
    Acta Diabetol; 2015 Dec; 52(6):1025-35. PubMed ID: 25733399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.